Humana shares rise after Medicare Advantage Star Rating increase
Humana (HUM) saw its stock surge approximately 13% in after-hours trading following an upgrade in the 2027 Medicare Advantage Star Ratings for one of its major plans. The plan, identified as H5216 and covering around 2.4 million members, received a rating increase from 3.5 stars to 4 stars. The improvement in ratings is significant because higher star ratings can influence consumer choice and potentially impact reimbursement rates under Medicare Advantage contracts. This upgrade may enhance the company's competitive position within its market segment. Investors reacted positively to this news, reflecting confidence that improved performance metrics could lead to better enrollment outcomes or favorable regulatory treatment.
Tickers: $HUM
Topics: government_regulation healthcare insurance